Bad news as Geron to quit hESC SCI trial for financial reasons
Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury. This is a very sad day for stem cell science. (Update in 2020: the firm still exists, but is working in different areas. The stock has struggled.) No more spinal cord […]
Bad news as Geron to quit hESC SCI trial for financial reasons Read More »